MANFREDINI, Rossella
 Distribuzione geografica
Continente #
NA - Nord America 21.181
AS - Asia 9.008
EU - Europa 8.538
SA - Sud America 1.250
Continente sconosciuto - Info sul continente non disponibili 269
AF - Africa 222
OC - Oceania 51
Totale 40.519
Nazione #
US - Stati Uniti d'America 20.609
GB - Regno Unito 2.576
SG - Singapore 2.444
CN - Cina 2.144
IT - Italia 2.087
HK - Hong Kong 1.355
VN - Vietnam 990
SE - Svezia 943
BR - Brasile 919
DE - Germania 629
BD - Bangladesh 513
RU - Federazione Russa 421
FI - Finlandia 419
FR - Francia 406
KR - Corea 349
CA - Canada 297
UA - Ucraina 277
TR - Turchia 257
IN - India 201
ID - Indonesia 160
BG - Bulgaria 121
NL - Olanda 113
AR - Argentina 107
MX - Messico 84
JP - Giappone 81
PL - Polonia 76
IQ - Iraq 74
SI - Slovenia 68
ZA - Sudafrica 66
PK - Pakistan 65
CO - Colombia 56
BE - Belgio 53
EC - Ecuador 51
ES - Italia 51
AU - Australia 47
IE - Irlanda 47
IR - Iran 43
LT - Lituania 43
AE - Emirati Arabi Uniti 38
KE - Kenya 38
SA - Arabia Saudita 38
CL - Cile 37
CZ - Repubblica Ceca 33
MA - Marocco 29
MY - Malesia 29
UZ - Uzbekistan 29
CR - Costa Rica 25
PH - Filippine 25
VE - Venezuela 25
AT - Austria 24
TW - Taiwan 24
TT - Trinidad e Tobago 22
GT - Guatemala 21
DZ - Algeria 20
EG - Egitto 20
JM - Giamaica 20
SV - El Salvador 20
CH - Svizzera 19
IL - Israele 19
TN - Tunisia 19
HN - Honduras 18
NI - Nicaragua 18
PR - Porto Rico 17
QA - Qatar 17
NP - Nepal 16
PY - Paraguay 16
BO - Bolivia 15
PT - Portogallo 15
AL - Albania 13
EU - Europa 13
PE - Perù 12
RO - Romania 12
GR - Grecia 11
AZ - Azerbaigian 10
DK - Danimarca 10
TH - Thailandia 10
EE - Estonia 9
JO - Giordania 9
RS - Serbia 9
HU - Ungheria 8
OM - Oman 8
UY - Uruguay 8
KG - Kirghizistan 7
LU - Lussemburgo 7
MN - Mongolia 7
BH - Bahrain 6
CW - ???statistics.table.value.countryCode.CW??? 6
DO - Repubblica Dominicana 6
KZ - Kazakistan 6
NO - Norvegia 6
PS - Palestinian Territory 6
AM - Armenia 5
BY - Bielorussia 5
GP - Guadalupe 5
MD - Moldavia 5
SK - Slovacchia (Repubblica Slovacca) 5
SN - Senegal 5
BB - Barbados 4
GD - Grenada 4
GE - Georgia 4
Totale 40.189
Città #
Ashburn 2.454
Southend 1.849
Santa Clara 1.619
Fairfield 1.588
Singapore 1.476
Hong Kong 1.318
San Jose 1.177
Chandler 1.015
Woodbridge 979
Houston 747
Council Bluffs 680
Seattle 626
Ann Arbor 555
Wilmington 542
Cambridge 531
Nyköping 514
Hefei 501
Beijing 481
Jacksonville 439
Chicago 431
Los Angeles 426
Dearborn 399
London 379
Modena 321
Seoul 317
Ho Chi Minh City 301
Helsinki 286
New York 256
Hanoi 220
The Dalles 219
Salt Lake City 187
Milan 172
San Diego 172
Buffalo 142
Munich 128
Izmir 127
Princeton 123
Dallas 119
Sofia 117
Jakarta 112
Shanghai 109
Bologna 107
São Paulo 100
Lauterbourg 97
Tampa 88
Moscow 87
Eugene 86
Rome 84
Toronto 75
Fremont 72
Montreal 71
Elk Grove Village 68
Orem 68
Phoenix 68
Columbus 66
Frankfurt am Main 65
Des Moines 64
Reggio Emilia 57
Tokyo 57
Denver 55
Boardman 53
Bremen 53
Turku 52
Da Nang 50
Miami 50
Brooklyn 49
Warsaw 47
Brussels 46
Redwood City 44
Falls Church 43
Shenzhen 43
Dublin 42
Atlanta 41
Haiphong 41
Nuremberg 40
Lancaster 39
Sterling 38
Falkenstein 36
Florence 36
Hillsboro 33
Chennai 32
Johannesburg 32
Parma 32
Dong Ket 31
Manchester 31
Mexico City 30
Naples 30
Ottawa 30
Nairobi 28
Biên Hòa 27
Brasília 27
Palermo 27
Turin 27
Detroit 26
San Francisco 26
Sant'Ilario d'Enza 25
Amsterdam 24
Miano 24
North Bergen 24
Rio de Janeiro 24
Totale 27.022
Nome #
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms 589
c-Myb supports erythropoiesis through the transactivation of KLF1 and LMO2 expression. 532
c-Myb supports erythropoiesis by transactivating KLF1 and LMO2 expression 525
Implementation of an NGS-based workflow for BRCA1 and BRCA2 mutation screening 485
miR-382-5p Controls Hematopoietic Stem Cell Differentiation Through the Downregulation of MXD1 482
Involvement of MAF/SPP1 axis in the development of bone marrow fibrosis in PMF patients 480
Virally mediated MafB transduction induces the monocyte commitment of human CD34+ hematopoietic stem/progenitor cells 473
C-Myb Restrains Megakaryopoiesis through the Hsa-MiR-486-3p-Driven Down-Regulation of C-Maf 470
Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells 432
Bone marrow-derived hematopoietic cells undergo myogenic differentiation following a Pax-7 independent pathway 431
Genomic landscape of megakaryopoiesis and platelet function defects 419
Purinergic signaling inhibits human acute myeloblastic leukemia cell proliferation, migration, and engraftment in immunodeficient mice 419
CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles 418
Eosinophils, but not neutrophils, exibit an efficient DNA repair machinary and high nucleolar activity 416
Unravelling the Complexity of Inherited Retinal Dystrophies Molecular Testing: Added Value of Targeted Next-Generation Sequencing 412
Co-culture of hematopoietic stem/progenitor cells with human osteblasts favours mono/macrophage differentiation at the expense of the erythroid lineage 412
The extracellular nucleotide UTP is a potent inducer of hematopoietic stem cell migration 412
Correlation between differentiation plasticity and mRNA expression profiling of CD34+-derived CD14- and CD14+ human normal myeloid precursors 410
Calreticulin Ins5 and Del52 mutations impair unfolded protein and oxidative stress responses in K562 cells expressing CALR mutants 404
Transcriptional profiles in melanocytes from clinically unaffected skin distinguish the neoplastic growth pattern in patients with melanoma 401
Integrative Analysis Of mRNA/miRNA Expression Profiles Identified JARID2 As a Shared Target Of Deregulated Mirnas In Primary Myelofibrosis 397
Calreticulin affects hematopoietic stem/progenitor cell fate by impacting erythroid and megakaryocytic differentiation 392
Amplicon-based next-generation sequencing: an effective approach for the molecular diagnosis of epidermolysis bullosa 389
MicroRNA expression profile in granulocytes from primary myelofibrosis patients 388
miR-494-3p overexpression promotes megakaryocytopoiesis in primary myelofibrosis hematopoietic stem/progenitor cells by targeting SOCS6 388
Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1) 387
Amplicon-based Next Generation Sequencing: an effective approach to molecular diagnosis of Epidermolysis Bullosa 387
Mutations and prognosis in primary myelofibrosis 383
Epidemiology and clinical relevance of mutations in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 359 patients of the AGIMM group 383
The kinetic status of hematopoietic stem cell subpopulations underlies a differential expression of genes involved in self-renewal, commitment, and engraftment. 378
Antisense inhibition of c-fes proto-oncogene blocks PMA-induced macrophage differentiation in HL60 and in FDC-P1/MAC-11 cells 372
Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study 370
Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary Myelofibrosis 365
Molecular profile of CD34+ stem/progenitor cells according to JAK2V617F mutation status in essential thrombocythemia. 363
miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesis 363
Identification of a molecular signature predictive of sensitivity to differentiation induction in acute myeloid leukemia 363
Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients 362
Isolation of human keratinocyte stem cells and high-throughput screening approach for their characterization 358
Analytic and Dynamic Secretory Profile of Patient-Derived Cytokine-Induced Killer Cells 357
Preclinical study for treatment of hypospadias by advanced therapy medicinal products 357
Requirement of the coiled-coil domains of p92(c-Fes) for nuclear localization in myeloid cells upon induction of differentiation 354
Extracellular purines promote the differentiation of human bone marrow-derived mesenchymal stem cells to the osteogenic and adipogenic lineages 354
Role of TGF-β1/miR-382-5p/SOD2 axis in the induction of oxidative stress in CD34+ cells from primary myelofibrosis 349
A functionally active RAR alpha nuclear receptor is expressed in retinoic acid non responsive early myeloblastic cell lines 347
Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations 339
Impact Of Prognostically Detrimental Mutations (ASXL1, EZH2, SRSF2, IDH1/2) On Outcomes In Patients With Myelofibrosis Treated With Ruxolitinib In COMFORT-II 339
Purinergic stimulation of human mesenchymal stem cells potentiates their chemotactic response to CXCL12 and increases the homing capacity and production of proinflammatory cytokines 336
A data-driven network model of primary myelofibrosis: transcriptional and post-transcriptional alterations in CD34+ cells 335
Gene expression profile of vitamin D3 treated HL60 cells shows an incomplete molecular phenotypic conversion to monocytes 332
Valproic acid triggers erythro/megakaryocyte lineage decision through induction of GFI1B and MLLT3 expression 330
Antiapoptotic effect of c-fes protooncogene during granulocytic differentiation 319
Expression And Function Of Nerve Growth-Factor And Nerve Growth-Factor Receptor On Cultured Keratinocytes. 317
Role of CD34 antigen in myeloid differentiation of human hematopoietic progenitor cells 313
Development of an IL-6 antagonist peptide that induces apoptosis in IL-6 dependent 7TD1 cells. 311
AMPLICON-BASED NGS: AN EFFECTIVE APPROACH FOR THE MOLECULAR DIAGNOSIS OF EPIDERMOLYSIS BULLOSA 310
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 310
Differential proteomic profile of leukemic CD34+ progenitor cells from chronic myeloid leukemia patients 310
Bone marrow-specific loss of ABI1 induces myeloproliferative neoplasm with features resembling, human myelofibrosis 309
Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low/neg accessory cells with dendritic-cell features 303
All-trans-retinoic acid induces simultaneously granulocytic differentiation and expression of inflammatory cytokines in HL-60 cells 297
Molecular and functional analysis of the stem cell compartment of chronic myelogenous leukemia reveals the presence of a CD34- cell population with intrinsic resistance to imatinib 295
Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia 292
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 292
Wnt/CTNNB1 signal transduction pathway inhibits the expression of ZFP36 in squamous cell carcinoma, by inducing transcriptional repressors SNAI1, SLUG and TWIST 292
Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis 290
SOX2 Is a Univocal Marker for Human Oral Mucosa Epithelium Useful in Post-COMET Patient Characterization 290
BTK Inhibitors Impair Platelet-Mediated Antifungal Activity 289
Terminal differentiation 288
Chromosome 9p trisomy increases stem cells clonogenic potential and fosters T-cell exhaustion in JAK2-mutant myeloproliferative neoplasms 287
Mutated clones driving leukemic transformation are already detectable at the single-cell level in CD34-positive cells in the chronic phase of primary myelofibrosis 286
Characterisation and discovery of novel miRNAs and moRNAs in JAK2V617F mutated SET2 cells 285
The isopeptidase inhibitor 2cPE triggers proteotoxic stress and ATM activation in chronic lymphocytic leukemia cells 279
Expression of B7 costimulatory molecule in cultured human epidermal Langerhans cells is regulated at the mRNA level. 278
ANTISENSE STRATEGIES TO CHARACTERIZE THE ROLE OF GENES AND ONCOGENES INVOLVED IN MYELOID DIFFERENTIATION 278
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 274
Chromosome 9p Duplication Promotes T-Cell Exhaustion and Enhances Stem Cell Clonogenic Potential in JAK2-Mutant Myeloproliferative Neoplasms 274
Molecular and functional characterization of CD133+ stem/progenitor cells infused in patients with end-stage liver disease reveals their interplay with stromal liver cells 272
Genomic analysis of hematopoietic stem cell at the single-cell level: Optimization of cell fixation and whole genome amplification (WGA) protocol 271
Characterization of new ATM deletion associated with hereditary breast cancer 269
Presence of a functional vitamin D receptor does not correlate with vitamin D3 phenotypic effects in myeloid differentiation 266
The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis 263
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 262
Neoantigen-specific T-cell immune responses: The paradigm of NPM1-mutated acute myeloid leukemia 262
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model 261
Cytokine-induced killer cells express CD39, CD38, CD203a, CD73 ectoenzymes and P1 adenosinergic receptors 260
Automated capture-based NGS workflow: one thousand patients experience in a clinical routine framework 254
Antisense strategies in leukemias 252
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: An international study of 797 patients 252
ROLE OF C-FES PROTOONCOGENE IN MYELOID DIFFERENTIATION 250
Tie2 expressing monocytes in the spleen of patients with primary myelofibrosis 247
Mechanistic insight into WEB-2170-induced apoptosis in human acute myelogenous leukemia cells. the crucial role of PTEN. 241
Physiological levels of 1 alpha, 25 di-hydroxyvitamin D3 induce the monocytic commitment of CD34+ hematopoietic progenitors 240
Prognostic Relevance of Multi-Antigenic Myeloma-Specific T-Cell Assay in Patients with Monoclonal Gammopathies 238
MITOCHONDRIAL-DNA DELETION IN A PATIENT WITH PROGRESSIVE OPHTHALMOPLEGIA 238
Gene Expression profile of Vitamin D3 treated HL60 cells shows a phenotypic but not a complete functional conversion to monocytes 233
Cultured Normal Human Keratinocytes Secrete Stem-Cell Factor And Express C-Kit Receptor 233
Novel Molecular Insights into Leukemic Evolution of Myeloproliferative Neoplasms: A Single Cell Perspective 231
Integrative analysis of copy number and gene expression data suggests novel pathogenetic mechanisms in primary myelofibrosis 230
Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: Pathogenetic insight and diagnostic value 229
Inhibition of c-fes expression by an antisense oligomer causes apoptosis oh HL60 cells induced to granulocytic differentiation 228
Totale 33.589
Categoria #
all - tutte 160.180
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 160.180


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.967 0 0 0 162 124 153 137 151 265 196 430 349
2022/20233.118 379 406 297 272 333 409 67 284 345 44 143 139
2023/20242.073 81 91 171 177 325 177 303 252 41 72 117 266
2024/20256.651 178 65 120 395 1.226 933 603 449 741 287 827 827
2025/202613.046 807 473 882 1.510 2.356 832 1.583 625 1.244 1.251 798 685
2026/20273.177 358 658 868 1.293 0 0 0 0 0 0 0 0
Totale 40.519